Community Research and Development Information Service - CORDIS

FP6

HIV/AIDS, Europe leading the global fight

Funded under: FP6-LIFESCIHEALTH

Abstract

While HIV/AIDS treatment has dramatically improved during the last ten years, current therapeutic options are still limited. Current treatments do not eradicate the virus. They are expensive, complicated and not available everywhere. Many treatments have side effects and induce viral resistance.
Consequently, there is a continuing need for new and better anti-HIV drugs. These can take the form of novel chemical compounds that attack known or new viral targets in the HIV replication cycle, or that interfere with cellular co-factors required for HIV replication.

Download application/pdf (113924)

Record Number: 7230 / Last updated on: 2006-03-01
Category: MISC